Effect of LCZ696 and Its Components Sacubitril and Valsartan on Insulin Secretion and Glucose Homeostasis in Mice

被引：0
|
作者：
Esser, Nathalie
Schmidt, Christine R.
Barrow, Breanne
Cronic, Laura
Hackney, Daryl J.
Mongovin, Steve M.
Hull, Rebecca L.
Zraika, Sakeneh
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1797-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1797-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of food on the oral bioavailability of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan (LCZ696) in healthy subjects
    Ayalasomayajula, Surya
    Langenickel, Thomas H.
    Chandra, Priya
    Wolfson, Edward D.
    Albrecht, Diego
    Zhou, Wel
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (12) : 1012 - 1018
  • [22] In vitro and clinical evaluation of OATP-mediated drug interaction potential of sacubitril/valsartan (LCZ696)
    Ayalasomayajula, S.
    Han, Y.
    Langenickel, T.
    Malcolm, K.
    Zhou, W.
    Hanna, I.
    Alexander, N.
    Natrillo, A.
    Goswami, B.
    Hinder, M.
    Sunkara, G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (04) : 424 - 431
  • [23] Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization
    Desai, Akshay S.
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael R.
    Rouleau, Jean L.
    Swedberg, Karl
    Shi, Victor
    Lefkowitz, Martin
    Starling, Randall
    Teerlink, John
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (03) : 242 - 248
  • [24] Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
    Jhund, Pardeep S.
    Fu, Michael
    Bayram, Edmundo
    Chen, Chen-Huan
    Negrusz-Kawecka, Marta
    Rosenthal, Arvo
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    McMurray, John J. V.
    Packer, Milton
    EUROPEAN HEART JOURNAL, 2015, 36 (38) : 2576 - 2584
  • [25] Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
    Shi, Victor
    Senni, Michele
    Streefkerk, Hendrik
    Modgill, Vikas
    Zhou, Wenchun
    Kaplan, Allen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 118 - 123
  • [26] Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥ 65 Years) With Systolic Hypertension
    Supasyndh, Ouppatham
    Wang, Jian'an
    Hafeez, Kudsia
    Zhang, Ying
    Zhang, Jack
    Rakugi, Hiromi
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (12) : 1163 - 1169
  • [27] Diode array detection for stability assessment and evaluation of degradation kinetics of newly introduced sacubitril in its supramolecular complex (LCZ696) with valsartan
    Ragab, Marwa A. A.
    Korany, Mohamed A.
    Galal, Shereen M.
    Ahmed, Aya R.
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2018, 41 (01) : 33 - 42
  • [28] Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation
    Mochel, Jonathan P.
    Teng, Chi Hse
    Peyrou, Mathieu
    Giraudel, Jerome
    Danhof, Meindert
    Rigel, Dean F.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 128 : 103 - 111
  • [29] The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway
    Gundersen, V.
    Eklund, O.
    Hancock, E.
    Hussain, R.
    Ohna, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 203 - 203
  • [30] Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects
    Yi Han
    Surya Ayalasomayajula
    Wei Pan
    Fan Yang
    Yaozong Yuan
    Thomas Langenickel
    Markus Hinder
    Sampath Kalluri
    Parasar Pal
    Gangadhar Sunkara
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 109 - 116
12345